News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current KRON market cap is 58.32M. The company's latest EPS is USD -1.9321 and P/E is -0.53.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 1.22M | 1.86M | 918k |
| Operating Income | -33.54M | -33.68M | -28.49M | -32.17M | -33.82M |
| Net Income | -32.26M | -31.78M | -26.24M | -29.74M | -31.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 6.29M |
| Operating Income | -16.82M | -58.04M | -151.4M | -137.12M | -121.83M |
| Net Income | -16.12M | -88.44M | -151.08M | -133.2M | -112.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 317.67M | 294.94M | 289.03M | 260.62M | 237.99M |
| Total Liabilities | 49.98M | 50.44M | 63.42M | 57.27M | 59.37M |
| Total Equity | 267.69M | 244.5M | 225.61M | 203.34M | 178.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 102.69M | 511.96M | 391.48M | 294.94M | 213.28M |
| Total Liabilities | 2.98M | 46.45M | 46.38M | 50.44M | 54.2M |
| Total Equity | -23.2M | 465.52M | 345.1M | 244.5M | 159.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -68.4M | -90.93M | -5.95M | -30.97M | -53.56M |
| Investing | -63.96M | -32.22M | -6.36M | -981k | 34.81M |
| Financing | 1.57M | 851k | N/A | 376k | 376k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.08M | -37.91M | -117.92M | -90.93M | -78.58M |
| Investing | -67.58M | -160.24M | 63.72M | -32.22M | 66.37M |
| Financing | 105.01M | 415.61M | 4.46M | 851k | 567k |
| Market Cap | 58.32M |
| Price to Earnings Ratio | -0.53 |
| Price to Sales Ratio | 9.46 |
| Price to Cash Ratio | 0.92 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 58.32M |
| Average Volume (1 week) | 1.25M |
| Average Volume (1 Month) | 477.49k |
| 52 Week Change | -27.01% |
| 52 Week High | 2.29 |
| 52 Week Low | 0.731 |
| Spread (Intraday) | 0.04 (3.82%) |
| Company Name | Kronos Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.kronosbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
